Szela Mary T
Insider CIK 1410289 · ALIM Director · AEGR Chief Executive Officer, Director · KURA Director · RCPT Director · CHRS Director · ABSI Director · RXDX Director · TLSI CEO and President, Director · OMGA Director · NVLN Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLSI TriSalus Life Sciences, In | F Tax w/h | 2026-10-05 | 2026-10-07 | 2,693 | $4.38 | $11.8K | 1,074,990 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2026-06-30 | 2026-07-01 | 3,990 | $3.87 | $15.4K | 1,077,683 | SEC↗ |
| ABSI Absci Corp | P Buy | 2026-06-30 | 2026-07-06 | 12,900 | $11.54 | $148.9K | 21,300 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2026-06-04 | 2026-06-08 | 39,800 | — | $0 | 39,800 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2026-06-04 | 2026-06-15 | 33,200 | — | $0 | 33,200 | SEC↗ |
| ABSI Absci Corp | A Award | 2026-06-04 | 2026-06-08 | 10,100 | — | $0 | 10,100 | SEC↗ |
| ABSI Absci Corp | A Award | 2026-06-04 | 2026-06-15 | 8,400 | — | $0 | 8,400 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2026-05-15 | 2026-05-18 | 39,682 | $2.59 | $102.8K | 1,065,215 | SEC↗ |
| TLSI TriSalus Life Sciences, In | S Sale | 2026-03-17 | 2026-03-20 | 15,944 | $3.85 | $61.4K | 752,987 | SEC↗ |
| TLSI TriSalus Life Sciences, In | S Sale | 2026-03-11 | 2026-03-20 | 4,358 | $4.13 | $18.0K | 768,931 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2026-02-23 | 2026-02-23 | 30,487 | $4.10 | $125.0K | 773,289 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-11-24 | 2025-11-25 | 250,000 | — | $0 | 1,578,182 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-11-24 | 2025-11-25 | 125,000 | — | $0 | 442,802 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-11-24 | 2025-11-25 | 300,000 | — | $0 | 742,802 | SEC↗ |
| ABSI Absci Corp | A Award deriv | 2025-07-07 | 2025-07-09 | 178,400 | — | $0 | 178,400 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 28,500 | — | $0 | 28,500 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-02-18 | 2025-02-19 | 21,089 | — | $0 | 465,348 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2025-01-30 | 2025-01-31 | 5,010 | $5.28 | $26.5K | 444,259 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2025-01-29 | 2025-01-31 | 5,030 | $5.03 | $25.3K | 439,249 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2025-01-28 | 2025-01-29 | 4,716 | $5.12 | $24.1K | 434,219 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2025-01-27 | 2025-01-29 | 240,000 | — | $0 | 240,000 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2025-01-27 | 2025-01-29 | 40,000 | — | $0 | 424,677 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2025-01-27 | 2025-01-29 | 4,826 | $5.42 | $26.2K | 429,503 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2024-09-13 | 2024-09-13 | 6,000 | $5.00 | $30.0K | 384,677 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2024-09-13 | 2024-09-13 | 1,295 | $4.83 | $6.3K | 378,677 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2024-09-12 | 2024-09-13 | 7,520 | $5.20 | $39.1K | 377,382 | SEC↗ |
| TLSI TriSalus Life Sciences, In | P Buy | 2024-09-10 | 2024-09-12 | 5,000 | $4.97 | $24.9K | 369,862 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,000 | — | $0 | 26,000 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2024-02-13 | 2025-11-25 | 125,000 | — | $0 | 317,802 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2024-02-13 | 2024-02-14 | 288,750 | — | $0 | 288,750 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award | 2024-02-13 | 2024-02-14 | 84,899 | — | $0 | 364,862 | SEC↗ |
| TLSI TriSalus Life Sciences, In | A Award deriv | 2023-08-14 | 2023-08-15 | 172,500 | — | $0 | 172,500 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 40,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 20,500 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 2,071 | — | $0 | 0 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 18,118 | — | $0 | 18,118 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 26,000 | — | $0 | 26,000 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award | 2023-05-19 | 2023-05-19 | 2,071 | — | $0 | 2,071 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2022-06-21 | 2022-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 18,118 | — | $0 | 18,118 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-05-19 | 2022-05-20 | 20,500 | — | $0 | 20,500 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2021-03-11 | 2021-03-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CHRS | A Award deriv | 2021-01-11 | 2021-01-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-24 | 20,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-24 | 20,000 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-24 | 14,997 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-06-22 | 2020-06-24 | 20,000 | $10.05 | $201.0K | 34,997 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | S Sale | 2020-06-22 | 2020-06-24 | 54,997 | $17.58 | $966.8K | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-06-22 | 2020-06-24 | 20,000 | $12.37 | $247.4K | 54,997 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | M Exercise | 2020-06-22 | 2020-06-24 | 14,997 | $2.50 | $37.5K | 14,997 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2020-06-18 | 2020-06-22 | 3,333 | — | $0 | 3,333 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2020-01-10 | 2020-01-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2019-06-19 | 2019-06-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2019-01-11 | 2019-01-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-11-06 | 2018-11-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-11-06 | 2018-11-08 | 7,583 | — | $0 | 7,583 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2018-06-19 | 2018-06-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2017-05-17 | 2017-05-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | M Exercise deriv | 2017-05-09 | 2017-05-11 | 6,632 | — | $0 | 13,264 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | F Tax w/h | 2017-05-09 | 2017-05-11 | 2,248 | $9.42 | $21.2K | 4,384 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | M Exercise | 2017-05-09 | 2017-05-11 | 6,632 | — | $0 | 6,632 | SEC↗ |
| NVLN NOVELION THERAPEUTICS INC. | A Award deriv | 2016-12-22 | 2016-12-27 | 323,520 | — | $0 | 323,520 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 600,000 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 194,000 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 97,000 | — | $0 | 0 | SEC↗ |
| NVLN QLT INC/BC | A Award deriv | 2016-11-29 | 2016-12-01 | 99,483 | — | $0 | 99,483 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2016-05-24 | 2016-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2016-05-09 | 2016-05-11 | 194,000 | — | $0 | 194,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2016-05-09 | 2016-05-11 | 97,000 | — | $0 | 97,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2016-01-07 | 2016-01-11 | 600,000 | — | $0 | 600,000 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 18,800 | $192.52 | $3.62M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 7,400 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-05-28 | 2015-06-01 | 7,400 | — | $0 | 7,400 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-04-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | A Award deriv | 2015-04-01 | 2015-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-07-28 | 2014-07-29 | 18,800 | — | $0 | 18,800 | SEC↗ |